Ting-Rong Chern

Title: Innovations of Inventor Ting-Rong Chern

Introduction

Ting-Rong Chern is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical enzymes involved in various diseases. With a total of 2 patents, his work has the potential to impact the treatment of serious health conditions.

Latest Patents

Chern's latest patents include "3,5-N-trihydroxy-alkanamide and derivatives: method for making same and use thereof." This invention provides novel compounds that act as inhibitors of histone deacetylases (HDACs) and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR). The compounds are designed to treat diseases associated with these enzymes, such as cancer and hypercholesterolemia. Another significant patent is "Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase," which also focuses on the same inhibitors and their therapeutic applications.

Career Highlights

Ting-Rong Chern has worked with prestigious institutions such as Academia Sinica and National Taiwan University. His research has been pivotal in advancing the understanding of enzyme inhibitors and their role in treating various diseases. His innovative approach has garnered attention in the scientific community.

Collaborations

Chern has collaborated with notable colleagues, including Jung-Hsin Lin and Jim-Min Fang. These partnerships have contributed to the development of his groundbreaking patents and have enhanced the research output in his field.

Conclusion

Ting-Rong Chern's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and offer promising avenues for treating serious health conditions.